SAMANTHA LAGACE: Open Payments
NPI 1790073724 · ALTAMONT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 91 payments from 18 companies in 2025. Trend: 2023 $1,773 · 2024 $2,157 · 2025 $1,657
Food & beverage: $1,657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $366 |
| Janssen Biotech, Inc. | 8 | $212 |
| GENZYME CORPORATION | 6 | $176 |
| Galderma Laboratories, L.P. | 18 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $117 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $90 |
| UCB, Inc. | 3 | $88 |
| Incyte Corporation | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Lilly USA, LLC | 3 | $62 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, Bimzelx, NEMLUVIO, COSENTYX, OPZELURA.
Industry payments across NY — which companies pay providers there.
